Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

25 oct. 2022 06h00 HE | Source: Provectus Biopharmaceuticals Inc.

Provectus Biopharmaceuticals Expands Research Collaboration with The Rockefeller University to Investigate Clinical-Stage Immuno-Dermatology Agent PH-10 for Skin Inflammation

KNOXVILLE, TN, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has expanded its sponsored research program with James G. Krueger, MD, PhD, Co-director,...
08 juin 2022 07h45 HE | Source: Allied Market Research

Global Apheresis Market to Hit $5.3 Billion by 2031: Allied Market Research

Portland, OR, June 08, 2022 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Apheresis Market generated $2.4 billion in 2021, and is expected to reach $5.3...
08 sept. 2021 10h51 HE | Source: The Insight Partners

Leukapheresis Market ($133.90Mn by 2028) Growth Forecast at 8.7% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com

New York, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Leukapheresis Market: Key InsightsAccording to our new research study on “Leukapheresis Market to 2028 – Global Analysis and Forecast – by Product Type,...